🇺🇸 FDA
Patent

US 11753630

Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

granted A61KA61K48/005A61K48/0058

Quick answer

US patent 11753630 (Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene) held by Precision BioSciences, Inc. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision BioSciences, Inc.
Grant date
Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K48/005, A61K48/0058